Gabelli & Co Investment Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,650
Closed -$669K 302
2025
Q4
$669K Sell
30,650
-21,550
-41% -$448K 0.1% 140
2025
Q3
$1.12M Buy
52,200
+35,850
+219% +$804K 0.18% 109
2025
Q2
$419K Buy
+16,350
New +$478K 0.06% 155

Other funds holding ATEX

Gabelli & Co Investment Advisers's ATEX Position: Q1 2026 in Review

Gabelli & Co Investment Advisers sold out of Anterix (ATEX) in Q1 2026, closing a stake of 30,650 shares — an estimated $669K sold.

Gabelli & Co Investment Advisers first reported a position in ATEX in Q2 2025 and held it in 3 quarters. The position peaked at $1.12M in Q3 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Gabelli & Co Investment Advisers reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 30,650 Anterix shares in Q1 2026, an estimated $669K.
  • Gabelli & Co Investment Advisers first reported a position in Anterix in Q2 2025 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's Anterix position peaked at $1.12M in Q3 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.